GH Research has reported its second quarter 2023 financial results, with updates on trials and cash on hand. The post GH Research Reports Q2 2023 Financial...
The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
Poor mental health affects not only quality of life but performance, resilience and career trajectories of athletes The post Psychedelics may help athletes’...
The company formulates synthetic psychedelic compounds for mental health treatments. The post Psychedelic Drug Library Earns Psilera U.S. Patent appeared...
The company expects its current cash to fund it into 2026. The post GH Research Progresses Deeper Into Toad Venom Research appeared first on Green Market...
Despite an overall lack of liquidity, institutional investors - and the FDA - seem more comfortable with psychedelics. The post Institutional Money Picks...
Atai Life Sciences Q2 financial results were released recently, alongside an update on the company’s pipeline progression. So, we figured it would be...
The mainstream media seemed to have it pinpointed: ayahuasca was the cause of these 58 fatalities. And ayahuasca’s mention in the headline offered undeniable...
Microdosing psychedelics is gaining popularity among people who are looking for ways to improve their lives. Microdosing involves taking a very small amount...